BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

Studies link sleep to psychiatry, immunity and memory

March 4, 2019
By Anette Breindl
Sleep is universal on both the species and the individual level. Though there have been reports of individuals, both in humans and other species, who need almost no sleep, a truly sleepless individual has never been identified.
Read More

CCR5 receptor has role in stroke recovery

Feb. 27, 2019
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

Feb. 25, 2019
By Anette Breindl
Scientists at the Technical University of Munich have demonstrated that sodium chloride increased the responses of T helper 2 (TH2) cells through several different mechanisms.
Read More

Exploiting IDH mutations restores glioma radiosensitivity

Feb. 22, 2019
By Anette Breindl

CCR5 receptor has role in stroke recovery

Feb. 22, 2019
By Anette Breindl
Blocking the CCR5 receptor on neurons enhanced the recovery from stroke and traumatic brain injury in animal studies, and patients with the delta32 mutation in CCR5, which renders the receptor nonfunctional, showed better recovery after mild to moderate stroke in the TABASCO clinical trial.
Read More

Exploiting IDH mutations restores glioma radiosensitivity

Feb. 19, 2019
By Anette Breindl
In findings that show a way to target tumors with mutations in isocitrate dehydrogenase 1 (IDH1), as well as bring new insights into the complexity of its effects, researchers have discovered that inhibiting cell cycle checkpoints or the DNA damage response could be a treatment option for gliomas with IDH1 mutations.
Read More

Bench Press: BioWorld looks at translational medicine

Feb. 19, 2019
By Anette Breindl
Researchers at the University of Wisconsin have discovered a link between fragile X syndrome (FXS) and Huntingtin (Htt) protein, better known for its role in Huntington's disease (HD). 
Read More

T cells ChAT with blood vessels via neurotransmitter

Feb. 14, 2019
By Anette Breindl

Bench Press: BioWorld looks at translational medicine

Feb. 11, 2019
By Anette Breindl
Scientists at the University of Salamanca have demonstrated that free radicals or reactive oxygen species (ROS) produced by astrocytes had a beneficial effect on brain metabolism. 
Read More

T cells ChAT with blood vessels via neurotransmitter

Feb. 11, 2019
By Anette Breindl
Researchers have shown that T cells produced the neurotransmitter acetylcholine to affect blood vessel dilation, which helped them control chronic infections. The work was published in the Feb. 8, 2019, issue of Science.
Read More
Previous 1 2 … 116 117 118 119 120 121 122 123 124 … 401 402 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • Skin irritation on hands

    HX-16108 holds promise for treating inflammatory skin diseases

    BioWorld Science
    Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing